Showing 21-26 of 26 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| FAME-1 Eye Trial Completion | The University of Sydney | Alicia Jenkins | Improving Lives | 01-July-2025 to 30-June-2028 | $545,454.35 |
| A paradigm shift in type 1 diabetes management – building the evidence to optimize care and enable access to disease modifying therapies in the young | The University of Western Australia | Aveni Haynes | Cures | 01-March-2024 to 28-February-2029 | $999,999.98 |
| ENHANCING TYPE 1 DIABETES RISK PREDICTION AND STRATIFICATION THROUGH INTEGRATED MULTI-OMICS PROFILING OF EARLY BIOMARKERS IN DRIED BLOOD SPOTS | University of New South Wales | Ki Wook Kim | Cures | 01-March-2023 to 29-February-2028 | $999,998.06 |
| Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes (TIRTLE2) | Victor Chang Cardiac Research Institute | Jennifer Snaith | Improving Lives | 01-September-2025 to 31-August-2028 | $1,231,999.24 |
| Different dynamic biomarkers of Type 1 Diabetes (T1D) | Western Sydney University | Wilson Wong | Cures | 01-March-2026 to 28-February-2029 | $285,000.00 |
| Early Prediction of Progression to Autoimmunity in Type 1 Diabetes | Western Sydney University | Anandwardhan Hardikar | Cures | 01-January-2023 to 31-December-2026 | $875,894.43 |